| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Santos David A | EVP, Chief Commercial Officer | RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO | /s/ Raymond Furey (Attorney-in-Fact) | 12 Feb 2026 | 0001820066 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RIGL | Common Stock | Tax liability | $122,763 | -3,546 | -7.5% | $34.62 | 43,440 | 10 Feb 2026 | Direct |